
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
Metastatic Breast CancerThe Epidemiological Strategy and Medical Economic (ESME) Ovarian cancer Data Platform is a multi-center real life database using a retrospective data collection process (18 FCCCs over 20 sites). This database compiles data from Patient's Electronic medical records (EMR), inpatient Hospitalisation records and Pharmacy records.

Application of Radiomics in Breast Cancer
Breast CancerUltrasound3 moreLittle is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.

What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience...
Breast CarcinomaThis study explores why patients may want to receive real-time imaging results during a screening mammogram appointment at an MD Anderson breast imaging center. Real-time imaging results means women receive the results of the mammogram right away during the same clinic visit. Information from this study may help researchers better understand patient preferences to enhance patient-experience driven care.

Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic...
Breast CancerProspective assessment of Quality of Life in patients with locally recurrent breast cancer after close R0, R1 or R2 resection or local inoperability and hyperthermic radiotherapy.

Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced...
Advanced Breast CancerHormone Receptor Positive Breast Carcinoma1 moreDescription of the choices for second line treatment, in the normal clinical practice of the centers adhering to the Hermione Network, in patients affected by advanced HR+/HER2- breast cancer who progressed after CDK4/6i in association with hormonal therapy.

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
Breast CancerResidualBreast cancer patients who undergo neoadjuvant systemic therapy and have residual breast cancer identified at the time of surgery exhibit a high (>50%) risk of future life-threatening recurrences and death.

PIONEER Study of Lifestyle Intervention to Reduced Breast Cancer Risk
Breast CancerLifestyle Risk ReductionA randomised controlled trial in which women discharged from the symptomatic breast clinic, who are above population risk (according to Tyrer Cuzick) will be asked to create lifestyle related goals. They will be told their estimated risk of developing breast cancer and will be randomised to one of three interventions: Breast cancer risk leaflet only lifestyle website lifestyle website plus group coaching. Fifty per cent of women will also be randomised to have Single Nucleotide Polymorphisms (SNPs) performed, and these will be incorporated into their risk score. The primary end point will be whether or not women achieve their lifestyle goal.

Swedish Ibrance Registries Insights (SIRI)
Malignant Neoplasm of BreastThe main objectives of this study are to describe patient characteristics, treatment patterns and clinical outcomes of patients receiving palbociclib in Swedish clinical practice.

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals...
Breast CarcinomaThis study collects information to implement MammoScreen for Breast Cancer Screening and Referrals. MammoScreen is a risk assessment questionnaire that identifies individuals at average and increased risk for breast cancer and guides their screening decisions.

Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk...
Breast CancerMagnetic Resonance ImagingUse Convolutional Neural Networks Analysis for Classification of Contrast-enhancing Lesions at Multiparametric Breast MRI. Build an abbreviated protocal, and investigate whether an abbreviated protocol was suitable for breast magnetic resonance imaging screening for breast cancer in high-risk Chinese women, which can shorten the examination time and avoid enhanced imaging while ensuring the accuracy of the diagnosis.